“We believe everyone should do their part through vaccination and masking to protect this vulnerable community.”

—Changchuan (Charles) Jiang, MD, MPH

Two new studies examine COVID-19 from the perspective of cancer survivors. One of the studies, which appears in the Journal of the National Cancer Institute (JNCI) (doi:10.1093/jnci/djab012), examines the prevalence among cancer survivors of medical factors associated with severe COVID-19 disease. The other study, published in the Journal of the National Comprehensive Cancer Network (JNCCN) (doi:10.6004/jnccn.2021.7113), compares the incidence of adverse events among cancer survivors and persons without a history of cancer after SARS-CoV-2 vaccination.

Considered together, these 2 studies should help reassure cancer survivors regarding the safety of COVID19 vaccination and should alert them to their increased risk of severe outcomes from SARS-CoV-2 infection.

“我们相信每个人都应该通过接种疫苗和戴口罩来保护这个脆弱的社区。”

——蒋长川（Charles）Jiang，医学博士，公共卫生硕士

两项新研究从癌症幸存者的角度检验了 COVID-19。其中一项研究发表在《美国国家癌症研究所杂志》 (JNCI) (doi:10.1093/jnci/djab012) 上，调查了癌症幸存者中与严重 COVID-19 疾病相关的医学因素的患病率。另一项发表在美国国家综合癌症网络杂志 (JNCCN) (doi:10.6004/jnccn.2021.7113) 上的研究比较了 SARS-CoV-2 疫苗接种后癌症幸存者和没有癌症病史的人的不良事件发生率.

综合考虑，这两项研究应有助于让癌症幸存者放心 COVID19 疫苗接种的安全性，并应提醒他们注意 SARS-CoV-2 感染导致严重后果的风险增加。